Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Jaguar Health Inc (NQ: JAGX ) 4.030 -0.080 (-1.95%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Jaguar Health Inc < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating ADHD September 21, 2023 Via ACCESSWIRE Jaguar Health Shares Presentation Replay Link from September 11-13, 2023 H.C. Wainwright Annual Global Investment Conference September 14, 2023 Via ACCESSWIRE Patent Issued in Japan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) September 13, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea September 12, 2023 Via ACCESSWIRE Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference September 11, 2023 Via ACCESSWIRE Jaguar Health's Executive VP Dr. Karen Brunke Joins BIO's Rare Disease and Orphan Drugs Committee September 07, 2023 Via ACCESSWIRE Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign August 24, 2023 Via ACCESSWIRE Jaguar Health Reports Second Quarter 2023 Financial Results August 14, 2023 Via ACCESSWIRE Jaguar Health to Hold Investor Webcast Monday, August 14th at 8:30 AM EDT Regarding Q2 2023 Financials & Corporate Updates August 10, 2023 Via ACCESSWIRE BioMedNewsBreaks – Jaguar Health Inc. (NASDAQ: JAGX) Announces Investor Engagement Campaign with B2i Digital September 05, 2023 Via Investor Brand Network Stocks That Hit 52-Week Lows On Wednesday August 30, 2023 On Wednesday, 59 companies achieved new lows for the year. Via Benzinga The Science Times Publishes Article About Jaguar Health's Focus on Developing Crofelemer for Two Rare Disease Indications August 30, 2023 Via ACCESSWIRE Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference August 28, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea August 17, 2023 Via ACCESSWIRE Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption August 16, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to BARDA for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea August 09, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease August 08, 2023 Via ACCESSWIRE Earnings Scheduled For August 14, 2023 August 14, 2023 Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. Via Benzinga Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea August 07, 2023 Via ACCESSWIRE Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC August 03, 2023 Via ACCESSWIRE REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th August 02, 2023 Via ACCESSWIRE Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS) August 01, 2023 Via ACCESSWIRE In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon July 27, 2023 Via ACCESSWIRE Jaguar Health Names Principal Investigators for Clinical Trial to Support Full Approval of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs July 26, 2023 Via ACCESSWIRE Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" July 25, 2023 Via ACCESSWIRE Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session July 24, 2023 Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest. Via Benzinga Jaguar Health Reports Approval of All Proposals at 2023 Annual Meeting of Stockholders July 07, 2023 Via ACCESSWIRE Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket June 29, 2023 Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday. Via Benzinga Napo Pharmaceuticals, a Jaguar Health Company, Submits Investigational New Drug (IND) Application to FDA for Microvillus Inclusion Disease June 28, 2023 Via ACCESSWIRE First U.S.-Based Canine Cancer Registry, Founded by Jaguar Health, Joins International Network to Help Advance Canine and Human Cancer Research June 26, 2023 Via ACCESSWIRE < Previous 1 2 3 4 5 6 7 8 9 ... 16 17 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.